Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128768) titled 'Mirabegron plus Celecoxib for Prevention of Catheter-Related Bladder Discomfort after TURBT: A Randomized Double-Blind Placebo-Controlled Trial' on July 25.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Third Xiangya Hospital Central South University
Condition:
Catheter-Related Bladder Discomfort (CRBD)
Intervention:
Control Group:Placebo
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-08-01
Target Sample Size: Control Group:65;Treatment Group:65;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?pr...